Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of lipid transport"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.998 | ||
| TLN1 | talin 1 | 0.938 | ||
| ALB | albumin | 0.783 | ||
| FN1 | fibronectin 1 | 0.762 | ||
| HP | haptoglobin | 0.643 | ||
| INSR | insulin receptor | 0.620 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.590 | ||
| ENG | endoglin | 0.586 | ||
| FHL2 | four and a half LIM domains 2 | 0.511 | ||
| APOA1 | apolipoprotein A-I | 0.411 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.349 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.259 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.256 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.229 | ||
| ITGB4 | integrin, beta 4 | 0.221 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.211 | ||
| PXN | paxillin | 0.209 | ||
| APOC1 | apolipoprotein C-I | 0.181 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.160 | ||
| APOE | apolipoprotein E | 0.153 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.139 | ||
| RARA | retinoic acid receptor, alpha | 0.121 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.119 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.117 | ||
| MAPT | microtubule-associated protein tau | 0.116 | ||
| A2M | alpha-2-macroglobulin | 0.114 | ||
| IRS1 | insulin receptor substrate 1 | 0.094 | Human | |
| NCF1 | neutrophil cytosolic factor 1 | 0.086 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.085 | ||
| APOA2 | apolipoprotein A-II | 0.084 | ||
| FLNA | filamin A, alpha | 0.082 | ||
| MED15 | mediator complex subunit 15 | 0.082 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.078 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.075 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.067 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.067 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.062 | ||
| CTGF | connective tissue growth factor | 0.062 | ||
| APOC3 | apolipoprotein C-III | 0.062 | ||
| THBS1 | thrombospondin 1 | 0.060 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.058 | ||
| CD63 | CD63 molecule | 0.056 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.050 | ||
| FOXO1 | forkhead box O1 | 0.043 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.043 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.043 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.043 | ||
| MED25 | mediator complex subunit 25 | 0.042 | ||
| RXRA | retinoid X receptor, alpha | 0.040 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.038 | ||
| PELI3 | pellino homolog 3 (Drosophila) | 0.035 | ||
| PRKCB | protein kinase C, beta | 0.035 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.035 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.033 | ||
| DTX1 | deltex homolog 1 (Drosophila) | 0.033 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.033 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.031 | ||
| CDCP1 | CUB domain containing protein 1 | 0.030 | ||
| APOC2 | apolipoprotein C-II | 0.029 | ||
| TTR | transthyretin | 0.029 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.028 | ||
| PRKCZ | protein kinase C, zeta | 0.026 | Human | |
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.026 | ||
| PLEC | plectin | 0.025 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.025 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.024 | ||
| PRKCA | protein kinase C, alpha | 0.022 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.021 | Human | |
| LDLR | low density lipoprotein receptor | 0.021 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.020 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.020 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.020 | ||
| ITGA6 | integrin, alpha 6 | 0.019 | Human | |
| ITGB5 | integrin, beta 5 | 0.019 | ||
| FOXO3 | forkhead box O3 | 0.019 | ||
| PALLD | palladin, cytoskeletal associated protein | 0.018 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.018 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.017 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.016 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.016 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.016 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.016 | ||
| IRS2 | insulin receptor substrate 2 | 0.015 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.015 | ||
| TRIM9 | tripartite motif containing 9 | 0.014 | ||
| BAD | BCL2-associated agonist of cell death | 0.014 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.014 | Human | |
| CD9 | CD9 molecule | 0.014 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.014 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.014 | ||
| MPZL1 | myelin protein zero-like 1 | 0.014 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.013 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.013 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.012 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.012 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.012 | ||
| DSE | dermatan sulfate epimerase | 0.012 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.012 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.012 | ||
| SNX9 | sorting nexin 9 | 0.012 | ||
| AHNAK | AHNAK nucleoprotein | 0.012 | ||
| SMAD3 | SMAD family member 3 | 0.012 | ||
| NUMB | numb homolog (Drosophila) | 0.012 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.011 | ||
| ZNF71 | zinc finger protein 71 | 0.011 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.011 | ||
| FGA | fibrinogen alpha chain | 0.011 | ||
| FAM83C | family with sequence similarity 83, member C | 0.011 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.011 | ||
| G3BP2 | GTPase activating protein (SH3 domain) binding protein 2 | 0.011 | ||
| DAO | D-amino-acid oxidase | 0.011 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.010 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.010 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.010 |